Tag: Health
Jim O’Neill Named HHS Deputy Secretary by Trump: Biotech Investor
President-elect Trump has selected biotech investor Jim O'Neill as the nominee for deputy secretary of the Health and Human Services department. If confirmed, O'Neill would be responsible for overseeing the day-to-day operations of various...
Title: Analysis of Alector Therapeutics’ Alzheimer’s Treatment Failure in Phase 2 Study
Alector Therapeutics announced that their Phase 2 trial for a potential Alzheimer's antibody, known as AL002, was unsuccessful. This setback is disappointing as the drug was considered a promising approach to treating the neurodegenerative...
The End of Cassava Sciences and its Alzheimer’s Drug: Lingering Damage
The story of Cassava Sciences came to a disappointing end on Monday when their experimental drug for Alzheimer's disease, simufilam, was found to be no more effective than a placebo in a large clinical...
Pfizer’s New R&D Head, VC Deep-Dive, and FDA Commissioner: What You Need to Know
Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally, the biotech venture capital landscape is set to see some...
FAQs: Understanding IGAs in Animals
Intentional Genomic Alterations (IGAs) in animals refer to changes made to an animal's DNA using modern molecular technologies. These alterations can include targeted DNA sequence changes like insertions, substitutions, or deletions, among others. Common...
Kura Oncology Licenses Leukemia Drug to Japanese Drugmaker
Kura Oncology and the Japanese drugmaker Kyowa Kirin have joined forces in a global partnership to work on Kura’s new treatment for acute leukemia. The drug, ziftomenib, is currently in a late-stage clinical trial...
Medicaid Official Criticizes Republican Reform as Poor Policy
Medicaid, a program that provides health coverage to millions of low-income Americans, is facing potential cuts as Republicans look to fund tax cuts and other priorities. The outgoing Medicaid chief under the Biden administration...
Apellis Triumphs while Astellas Faces Defeat
Good morning! Today, there is a lot of news from the American Heart Association's annual meeting, and former National Cancer Institute chief Ned Sharpless has launched a new biotech company called Jupiter.
Here's what you...
Dr. Oz appointed by Trump to head Medicare and Medicaid
President-elect Trump has chosen Dr. Mehmet Oz, a well-known surgeon and television personality, to lead the Centers for Medicare and Medicaid Services. This agency plays a crucial role in setting policies that affect payments...
Merck Drug Trial and Wegovy in China: Pharmalittle News Update
Good day to you! The Pharmalot team is here, ready to dive into the latest news in the pharmaceutical world. Today, we have some interesting updates to share with you, so grab a cup...
CAR-T Therapy Shows Promise for Treating Autoimmune Diseases without Impacting Fertility
President-elect Trump has nominated Robert F. Kennedy Jr. as the country’s new health secretary, which has caused a stir in the biotech community. Kennedy is known for being a vaccine skeptic, and his appointment...
RFK Jr.’s Potential Impact on Vaccine Maker Legal Protections as HHS Secretary
Robert F. Kennedy Jr., President-elect Trump's pick for secretary of Health and Human Services, is not a fan of laws that protect vaccine manufacturers from lawsuits. If he assumes the position, he could potentially...
